Print | Share | Contact Us | Search:


Date
Title (click to read)


May 22, 2013
NPS Pharmaceuticals to Present at Deutsche Bank Health Care Conference
May 21, 2013
NPS Pharmaceuticals Prices Public Offering of Common Stock
May 20, 2013
NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of its Common Stock
May 16, 2013
NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young Entrepreneur of the Year® 2013
May 15, 2013
NPS Pharmaceuticals Recognized by National Organization for Rare Disorders for Gattex® as an Innovative Treatment for Patients with Short Bowel Syndrome


News Release Archive



 
Stay informed


To stay apprised of NPS Pharmaceuticals press releases, financial reports and SEC filings as they are posted, sign up for Financial Alerts or SEC Alerts via email notification.

 


  Board of Directors
  Contact Us